Dr. Ramez Eskander, MD
Claim this profileUC San Diego Moores Cancer Center
Studies Ovarian Cancer
Studies Endometrial Adenocarcinoma
7 reported clinical trials
13 drugs studied
Area of expertise
1Ovarian Cancer
Stage IV
MMR negative
MMR positive
2Endometrial Adenocarcinoma
Stage III
Stage IV
MMR negative
Affiliated Hospitals
Clinical Trials Ramez Eskander, MD is currently running
ACR-368
for Ovarian Cancer
This trial tests a new drug, ACR-368, alone or with a small dose of another drug, gemcitabine, in patients whose cancers don't respond to standard treatments. A special test helps decide which treatment might work best for each patient. Gemcitabine has been used with other drugs for various cancers, including pancreatic, lung, ovarian, and breast cancers.
Recruiting1 award Phase 210 criteria
Mirvetuximab + Bevacizumab
for Ovarian Cancer
GLORIOSA is a Phase 3 multicenter, open label study designed to evaluate the safety and efficacy of mirvetuximab Soravtansine + Bevacizumab as maintenance therapy in participants with platinum-sensitive ovarian, primary peritoneal or fallopian tube cancers with high folate receptor-alpha (FRα) expression.
Recruiting2 awards Phase 3
More about Ramez Eskander, MD
Clinical Trial Related3 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Ramez Eskander, MD has experience with
- Carboplatin
- Paclitaxel
- Pembrolizumab
- Tazemetostat
- Nivolumab
- ADP-A2M4CD8
Breakdown of trials Ramez Eskander, MD has run
Ovarian Cancer
Endometrial Adenocarcinoma
Uterine Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ramez Eskander, MD specialize in?
Ramez Eskander, MD focuses on Ovarian Cancer and Endometrial Adenocarcinoma. In particular, much of their work with Ovarian Cancer has involved Stage IV patients, or patients who are MMR negative.
Is Ramez Eskander, MD currently recruiting for clinical trials?
Yes, Ramez Eskander, MD is currently recruiting for 3 clinical trials in La Jolla California. If you're interested in participating, you should apply.
Are there any treatments that Ramez Eskander, MD has studied deeply?
Yes, Ramez Eskander, MD has studied treatments such as Carboplatin, Paclitaxel, Pembrolizumab.
What is the best way to schedule an appointment with Ramez Eskander, MD?
Apply for one of the trials that Ramez Eskander, MD is conducting.
What is the office address of Ramez Eskander, MD?
The office of Ramez Eskander, MD is located at: UC San Diego Moores Cancer Center, La Jolla, California 92093 United States. This is the address for their practice at the UC San Diego Moores Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.